UPDATE: Goldman Maintains Buy On Humana, Raises Target To $425, Adds To Americas Conviction List Given Firm's Expectation Of Meaningful Upward Estimate Revisions To Consensus Estimates Due To Repeal Of Health Insurer Industry Fee